Eganelisib

A Phase 1b Open-Label Study to Evaluate the Safety and Tolerability of Eganelisib as Monotherapy and in Combination With Cytarabine in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Arms / Cohorts

Experimental:Eganelisib in Combination with Cytarabine

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Accepting patients

Experimental:Eganelisib

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Accepting patients

(888) 803-1766

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.